期刊文献+

维持性血液透析患者血清FGF-23与血管钙化的相关性探讨 被引量:3

下载PDF
导出
摘要 血管钙化是血管损伤、高血压、动脉粥样硬化、慢性肾病等较为普遍共同存在的病理表现,其主要症状为血管壁的僵硬性增加,顺应性降低,容易引起心力衰竭、心肌缺血等情况发生,促进血栓的形成、斑块破裂,是心血管疾病高病死率的重要原因。
出处 《华夏医学》 CAS 2018年第3期108-110,共3页 Acta Medicinae Sinica
基金 桂林市科学研究与技术开发计划资助项目(2016012704-1)
  • 相关文献

参考文献7

二级参考文献64

  • 1陈伟,崔天蕾,谢林伸,李昕怡,吴敬.不同血液净化方式对维持性血液透析患者微炎症状态和营养状态的影响[J].中国老年学杂志,2015,35(2):379-380. 被引量:45
  • 2London GM,Marchais SJ,Guerin AP,et al.Arteriosclerosis,vascular calcification and cardiovascular disease in uremia.Current Opinion in Nephrology and Hypertension,2005,14(6):538-542.
  • 3Rogers NM,Teubner DJ,Coates PT.Calcific uremic arteriolopathy:advances in pathog enesis and treatment.Semin Dial,2007,20(2):150-157.
  • 4Nasrallah MM,El-Shehaby AR,Salem MM,et al.Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients.Nephrol Dial Transplant,2010,25(8):2679-2685.
  • 5Jean G,Terrat JC,Vanel T,et al.High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.Nephrol Dial Transplant,2009,24(9):2792-2796.
  • 6Adragao T,Pires A,Lucas C,et al.A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients.Nephrol Dial Transplant,2004,19(6):1480-1488.
  • 7Ramon I,Kleynen P,Body JJ,et al.Fibroblast growth factor 23 and its role in phosphate homeostasis.Eur J Endocrinol,2010,162(1):1-10.
  • 8Yokota H,Raposo JF,Chen A,et al.Evaluation of the Role of FGF-23 in Mineral Metabolism.Gene Regul Syst Bio,2009,3(1):131-142.
  • 9Saito T,Fukumoto S.Fibroblast Growth Factor 23(FGF23) and Disorders of Phosphate Metabolism.Int J Pediatr Endocrinol 2009,2009:496514.
  • 10Gutierrez OM,Mannstadt M,Isakova T,et al.Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.N Engl J Med,2008,359(6):584-592.

共引文献61

同被引文献22

引证文献3

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部